Rare Benign and Uncertain Malignant Potential Tumors of Bladder: Review of the Literature
Journal Title: Üroonkoloji Bülteni - Year 2017, Vol 16, Issue 4
Abstract
The most common primary bladder cancer are transitional cell (urothelial) carcinomas. However, there are several uncommon but significant bladder lesions that must be differentiated from urothelial carcinomas. These bladder cancers are all rare and have been described in small series and isolated case reports. The different/specific treatment approaches of these rare tumors have made it important to recognize these tumors. In this review, common clinical signs, morphologic features and treatment approaches of these rarely isolated tumors are presented.
Authors and Affiliations
Cem Yücel, Mehmet Zeynel Keskin
Keywords
Related Articles
- EP ID EP369506
- DOI 10.4274/uob.673
- Views 90
- Downloads 0
A Rare Tumor: Small Cell Prostate Carcinoma Case Report
Prostate small cell carcinoma is a rare and aggressive tumor. They can be distinguished from classic prostate adenocarcinoma by features such as lack of prostate-specific antigen secretion, failure to respond to androgen...
Oncocytic Adrenocortical Carcinoma: A Rare Case Report
Oncocytic neoplasms of the adrenal cortex are uncommon and generally benign and non-functioning. About 20% of adrenocortical oncocytic neoplasms show malignant components. A 39-year-old woman with an adrenocortical oncoc...
Early and Late Complications of Urinary Diversions after Radical Cystectomy
One of the strongest predictive factors for the early and late postoperative complications and morbidity of radical cystectomy is the type of urinary diversion following cystectomy. In this paper, we reviewed English-lan...
A Rare Case Mimicking Ureteral Stone or Tumor: Intraureteral Organized Debris
Intraluminal ureteral debris, hematomas or foreign body, which may mimic ureteral stones and tumors, are extremely rare cases. While renal colic and macroscopic hematuria are generally the causes for presenting, establis...
Neutropenic Fever, Skin and Eye Toxicities Develops During Docetaxel Treatment in Metastatic Prostate Cancer: A Case Report
Prostate cancer is one of the most common tumors in men. Docetaxel and prednisone treatment are accepted as standard therapy in castration-resistant prostate cancer patients. Docetaxel is a chemotherapeutic drug of the t...